Atıf İçin Kopyala
Dinçer D., Ulukal Karancı E., Akın M., Adanır H.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, cilt.30, ss.505-510, 2019 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
30
-
Basım Tarihi:
2019
-
Doi Numarası:
10.5152/tjg.2019.19057
-
Dergi Adı:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.505-510
-
Anahtar Kelimeler:
Upper gastrointestinal bleeding, prophylaxis, proton-pump inhibitors, NSAID, antiaggregants, ANTIINFLAMMATORY DRUG-USE, PREVENTION, ASPIRIN, RISK, TOLERABILITY, CLOPIDOGREL, SAFETY
-
Akdeniz Üniversitesi Adresli:
Evet
Özet
Background/Aims: Using proton-pump inhibitor (PPI) is a protective option for patients who require long-term non-steroidal anti-inflammatory drugs (NSAIDs) and antiaggregants. In our previous study, the rate of PPI use in prophylaxis was found to be 2%. Here we aimed to investigate whether there is a change in PPI use in prophylaxis in a similar patient group after 10 years.